Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 6.111M
March 31, 2026 2.934M
December 31, 2025 2.921M
September 30, 2025 2.891M
June 30, 2025 2.842M
March 31, 2025 2.840M
December 31, 2024 2.833M
September 30, 2024 2.833M
June 30, 2024 2.828M
March 31, 2024 2.828M
December 31, 2023 2.818M
September 30, 2023 2.818M
June 30, 2023 1.193M
March 31, 2023 1.193M
December 31, 2022 1.180M
September 30, 2022 1.174M
June 30, 2022 0.9592M
March 31, 2022 0.9569M
Date Value
December 31, 2021 0.9469M
September 30, 2021 0.9413M
June 30, 2021 0.9354M
March 31, 2021 0.9312M
December 31, 2020 0.9234M
September 30, 2020 0.9059M
June 30, 2020 0.8997M
March 31, 2020 0.7762M
December 31, 2019 0.7704M
September 30, 2019 0.7623M
June 30, 2019 0.7558M
March 31, 2019 0.7504M
December 31, 2018 0.8234M
September 30, 2018 0.8233M
June 30, 2018 0.8234M
March 31, 2018 0.8234M
December 31, 2017 0.8233M
September 30, 2017 0.8233M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
United Therapeutics Corp. 42.68M
Arbutus Biopharma Corp. 197.63M
Kura Oncology, Inc. 88.95M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M